Related Experiment Video
Updated: Apr 12, 2026
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
High speed rotational atherectomy in coronary artery disease
P K Raju1, S H Stertzer1, R E Shaw1
1San Francisco Heart Institute, Seton Medical Center, Daly City, California.
Insights
Coronary artery disease remains a leading cause of death. Advances in percutaneous transluminal coronary angioplasty (PTCA) and devices like the Rotablator® now treat more complex coronary artery lesions effectively.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Coronary artery disease (CAD) is a leading cause of mortality in the United States.
- Percutaneous transluminal coronary angioplasty (PTCA), introduced in 1977, revolutionized CAD treatment.
- Initial PTCA was limited to simple, proximal, non-calcified lesions.
Purpose of the Study:
- To describe the technical aspects and clinical applications of high-speed rotational atherectomy.
- To highlight advancements in PTCA technology for complex coronary lesions.
- To evaluate the utility of newer devices in managing restenosis and complications.
Main Methods:
- Review of technical aspects of the Rotablator® device.
- Description of the high-speed rotational atherectomy procedure.
- Analysis of clinical applications for complex and calcified coronary lesions.
Main Results:
- Technological advancements have expanded PTCA capabilities to complex lesions and multivessel CAD.
- High-speed rotational atherectomy effectively treats long and calcified coronary lesions.
- Newer devices address restenosis and improve outcomes in challenging PTCA cases.
Conclusions:
- High-speed rotational atherectomy is a valuable tool for treating complex coronary artery disease.
- Advancements in interventional cardiology continue to improve PTCA efficacy and patient outcomes.
- Rotational atherectomy expands treatment options for previously untreatable coronary lesions.
Abstract:
Despite major advances in its diagnosis and management, coronary artery disease remains the major cause of death accounting for 45.3 percent of all deaths in the United States. One of the major milestones in the treatment of coronary artery disease has been the introduction of non-surgical revascularization in the form of percutaneous transluminal coronary angioplasty by Andreas Gmentzig in 1977. In the early years, PTCA could only be performed in proximal, discrete, non-calcified lesions. Over the last decade, major advances in the catheter, balloon and guide wire technology as well as increased operator experience extended the benefits of PTCA to patients with more complex lesions and multivessel coronary artery disease. Although the initial impetus for the development of newer devices has been to address the problem of restenosis, they are proving to be useful in treating lesions that are inadequately treated or subject to increased incidence of complications. The high speed rotational atherectomy is a valuable addition with its ability to treat long, calcified lesions. This report will describe the technical aspects of the Rotablator®, the procedure of high speed rotational atherectomy and its clinical applications.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:26Atherosclerosis III: Management
01:27Peripheral Artery Disease III: Interprofessional Care
01:30Coronary Artery Disease I: Introduction